Synlett 2024; 35(08): 862-876
DOI: 10.1055/a-2245-6202
account
Special Issue dedicated to Keith Fagnou

Harnessing the Power of C–H Functionalization Chemistry to Accelerate Drug Discovery

Bing Li
a   Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
,
Sriram Tyagarajan
a   Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
,
Kevin D. Dykstra
a   Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
,
Tim Cernak
b   Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA
,
Petr Vachal
a   Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
,
a   Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
› Author Affiliations


Dedicated to the memory of Professor Keith Fagnou. His legacy in contributing seminal advances to C–H functionalization chemistry and in training exceptional scientists has left a lasting impact on the field.

Abstract

The field of C–H functionalization chemistry has experienced rapid growth in the past twenty years, with increasingly powerful applications in organic synthesis. Recognizing the potential of this emerging field to impact drug discovery, a dedicated effort was established in our laboratories more than ten years ago, with the goal of facilitating the application of C–H functionalization chemistries to active medicinal-chemistry programs. Our approach centered around the strategy of late-stage functionalization (LSF) wherein C–H functionalization chemistry is employed in a systematic and targeted manner to generate high-value analogues from advanced drug leads. To successfully realize this approach, we developed broadly useful LSF chemistry platforms and workflows that increased the success rates of the C–H functionalization chemistries and accelerated access to new derivatives. The LSF strategy, when properly applied, enabled a rapid synthesis of molecules designed to address specific medicinal-chemistry issues. Several case studies are presented, along with descriptions of the group’s platforms and workflows.

1 Introduction

2 Building an LSF Chemistry Toolbox

2.1 C–H Borylation

2.2 Minisci Platforms

2.3 Automated Direct-Metalation Platform

3 Building an LSF Workflow

4 LSF Application Case Studies

4.1 BTK Inhibitor Program

4.2 GPR40 Agonist Program

5 Conclusions



Publication History

Received: 30 November 2023

Accepted after revision: 15 January 2024

Accepted Manuscript online:
15 January 2024

Article published online:
16 February 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany